Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Semin Thromb Hemost • April 25, 2020
To Maintain or Cease Non-Vitamin K Antagonist Oral Anticoagulants Prior to Minimal Bleeding Risk Procedures: A Review of Evidence and Recommendations. Semin Thromb Hemost • April 2, 2019
Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost • November 17, 2015
Venous thromboembolism prophylaxis in critically ill patients. Semin Thromb Hemost • October 21, 2015
Management of complications related to central venous catheters in cancer patients: an update. Semin Thromb Hemost • January 24, 2015
Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost • January 23, 2014
Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Semin Thromb Hemost • January 23, 2014
Diagnosis and management of common acquired bleeding disorders. Semin Thromb Hemost • January 23, 2014
Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost • February 28, 2010
Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost • April 29, 2009